‹ The Friday Upgrade · Past Issues · The Feature
TFU  
The
Friday Upgrade
"Depth,
once a week."
 
Thursday, July 23, 2026 The Feature
The Feature
 
The Peptide Boom, Explained
Half the gym is talking about them and most of it is wrong. Here is what peptides actually are, why they took over, and where the line is between medicine and a gamble.
Glass medicine vials, black and white

You have heard the word everywhere by now. In the gym, from that random health guru on your podcast, and from the guy at work who suddenly looks five years younger. Peptides. The problem is that almost nobody using the word can tell you what one actually is. So let us start there, because the whole thing makes more sense once you do.

A peptide is just a short chain of amino acids. Amino acids are the building blocks of protein. String a handful of them together and you get a peptide. Usually that is somewhere between two and fifty of them, linked in a chain. Your body already makes hundreds of these, and it uses them as messengers. One of the most common examples that many people have heard of is insulin, which is a peptide. Peptides also carry a lot of the signals that tell your body when to burn fat, build muscle, feel hungry, or start healing. This is the key idea. A peptide is not a sledgehammer like a steroid, which floods your system with an outside hormone. It is a note passed to a specific cell telling it to do more of something it already knows how to do.

That is also why almost all of them are injected. A peptide is a small piece of protein and your stomach exists to break protein apart. When you swallow most peptides, your gut destroys them before they ever reach your blood. So the standard way to take them is a small injection under the skin. That is a big part of why the whole peptide world can look a little intense from the outside. It runs on needles, not pills.

None of this is new science. The first peptide drug, insulin, has been keeping people alive for over a hundred years. More than eighty peptide medicines are already FDA approved and sitting in normal pharmacies. What changed is one specific class of them, and they are called GLP-1 peptides. These are the ones behind Ozempic, Wegovy, and Mounjaro. They worked so well and so publicly that they dragged the entire category into the spotlight. Millions of people watched a weekly shot completely reshape someone's body. A lot of them heard the word peptide for the first time and asked the obvious question. If this one can do that, what else is out there?

That one question turned a quiet corner of medicine into a full-blown boom. The timing was perfect. Longevity guys like Bryan Johnson and Peter Attia had already spent years making hardcore health optimization feel normal, and peptides fit right in. Then social media took over. Interest in peptides exploded almost overnight, influencers started handing out discount codes, and telehealth clinics turned it into a five-minute video call to get a vial in the mail. There is even a political push right now to loosen the rules. So a molecule most people could not define a year ago is now a normal thing to hear about.

Here is where it gets complicated and where you need to keep two very different groups of peptides straight in your head. The first group is the approved medicines. The GLP-1s for weight and blood sugar. Tesamorelin for a specific kind of fat. PT-141 for libido. These went through real trials, have known risks, and are meant to come with a doctor watching, though that does not always happen. Peptides are a new enough area that plenty of doctors are not fully up to speed on them yet. The second group is the one the gym is actually buzzing about. The recovery and longevity peptides. Names like BPC-157, TB-500, and the growth-hormone stimulators. These are a bit different. Most of them have not been approved for use in humans.

The FDA's handling of that second group is messy and still unfolding. For years the trendy ones lived in a gray zone, where specialty pharmacies were allowed to mix them up for patients under certain rules. Then the FDA started tightening. BPC-157 is probably the most hyped peptide of all. It got flagged over impurity and safety concerns and pushed into a restricted category. In 2026, it came off that restricted list. But it was not moved to the approved side either. That left it in a strange limbo, neither clearly legal nor clearly banned. The FDA has a committee reviewing several of these peptides right now to decide whether pharmacies can keep making them at all. Even as the political side pushes to open the gates, the FDA's own scientists have said plainly that the safety data is not there yet. In translation, the people who actually study this for a living are not comfortable, and the story is being written in real time.

That uncertainty matters, and it matters most to the guy actually thinking about trying one. Here is the real problem, and it comes down to where these peptides come from. The approved ones come from a pharmacy. The trendy ones mostly come from websites that label the vial "for research use only, not for human consumption," which is a wink wink kind of deal. That label is a legal dodge, not a safety standard, and the FDA has said so directly. When independent labs have tested gray-market peptide vials, the results are ugly. Roughly a third came back mislabeled, underdosed, or contaminated. Testers have found bacterial toxins that can cause a septic reaction, heavy metals left over from sloppy manufacturing, less than half the dose on the label, and in some vials the wrong peptide entirely. There are documented cases of real harm. You are not just gambling on whether the compound works. You are gambling on whether what is in the vial is even what the label says. Then you put it in your body, usually without any bloodwork first.

So when people ask which ones are good, the honest answer is that the question is backwards. The real split is not good peptide versus bad peptide. It is supervised and tested versus a coin flip you run on yourself. For the record, here is roughly where the big names stand. The GLP-1s are approved, well studied, and genuinely effective for what they treat. Tesamorelin and PT-141 are approved for their narrow uses. BPC-157 and TB-500 are the recovery favorites. Lots of promising animal data and plenty of gym testimonials, but almost no proper human trials. They are the ones stuck in that legal limbo. The growth-hormone stimulators are the next group. Names like CJC-1295, ipamorelin, and sermorelin. They nudge your body into making more of its own growth hormone. That sounds great, until you remember we do not have long-term data on what chasing that actually does to you. MOTS-c and copper peptides like GHK-Cu are the newer longevity and skin favorites. You will already find copper peptides in plenty of over-the-counter skin serums. It is the injectable, longevity-chasing version that is still early and unproven. Notice the pattern. The moment a peptide is genuinely proven and approved, it stops being a gray-market gamble and becomes a prescription. Everything still traded around in gym locker rooms is stuck there for one reason. The evidence is not in yet.

None of this is a reason to write the whole category off. Peptides are one of the most exciting areas in medicine, and some of them will almost certainly be part of how we treat aging and injury in ten years. The point is simpler than a yes or a no. If you are curious, the adult move is to go through an actual clinician who can order the real thing, watch your bloodwork, and tell you when to stop. The move that gets men hurt is the one the algorithm is pushing. A vial from a website, a protocol from a stranger, and your own body as the test subject. Just be careful about what you put in your body.

That's this week's Feature. Now that you're informed, get back to work. Forward it to anyone who'd use it.

The Friday Upgrade · fridayupgrade.com
TFU
Get the next Feature free.
One long read every Thursday, plus the full briefing on Friday.
Subscribe Free